The GLP-1 plotter allows you to visualize your medication levels over time based on your dosing schedule
It is intended for adults who have been on the 2.4 mg dose of Wegovy for at least four weeks but need additional weight loss
Others have moved in the opposite direction, limiting coverage due to budget concerns
This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Semaglutide is FDA-approved for weight loss in adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, high cholesterol, or type 2 diabetes
These treatments, including FDA-approved medications, promise long-term success beyond traditional diet and exercise